Celltrion, Inc. (068270.KS)
KRW 193100.0
(-3.06%)
KRW 193100.0
(-3.06%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 3759.00 KRW | -3.46% |
| 2022 | 3894.00 KRW | -2.65% |
| 2021 | 4000.00 KRW | 11.75% |
| 2020 | 3579.37 KRW | 71.75% |
| 2019 | 2084.07 KRW | 22.55% |
| 2018 | 1700.53 KRW | -33.33% |
| 2017 | 2550.83 KRW | 131.04% |
| 2016 | 1104.05 KRW | 5.49% |
| 2015 | 1046.64 KRW | 26.46% |
| 2014 | 827.63 KRW | 9.99% |
| 2013 | 752.46 KRW | -70.4% |
| 2012 | 2541.71 KRW | 109.6% |
| 2011 | 1212.64 KRW | 47.7% |
| 2010 | 821.01 KRW | 70.86% |
| 2009 | 480.53 KRW | 287.15% |
| 2008 | 124.12 KRW | -62.05% |
| 2007 | 327.06 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 377.58 KRW | 249.03% |
| 2024 Q1 | 108.30 KRW | 2027.7% |
| 2023 FY | - KRW | -3.46% |
| 2023 Q4 | 5.09 KRW | -99.68% |
| 2023 Q1 | 1156.00 KRW | 130.7% |
| 2023 Q3 | 1570.60 KRW | 51.8% |
| 2023 Q2 | 1034.63 KRW | -10.5% |
| 2022 Q4 | 501.09 KRW | -56.92% |
| 2022 Q3 | 1163.26 KRW | -8.78% |
| 2022 Q2 | 1275.21 KRW | 55.52% |
| 2022 Q1 | 819.99 KRW | -9.83% |
| 2022 FY | - KRW | -2.65% |
| 2021 Q3 | 921.95 KRW | 7.83% |
| 2021 Q1 | 1325.41 KRW | 85.34% |
| 2021 Q2 | 855.02 KRW | -35.49% |
| 2021 FY | - KRW | 11.75% |
| 2021 Q4 | 909.37 KRW | -1.36% |
| 2020 Q4 | 715.12 KRW | -38.15% |
| 2020 FY | - KRW | 71.75% |
| 2020 Q1 | 712.56 KRW | 2.19% |
| 2020 Q3 | 1156.18 KRW | 23.49% |
| 2020 Q2 | 936.22 KRW | 31.39% |
| 2019 Q1 | 422.49 KRW | 31.0% |
| 2019 FY | - KRW | 22.55% |
| 2019 Q3 | 404.89 KRW | -20.41% |
| 2019 Q4 | 697.26 KRW | 72.21% |
| 2019 Q2 | 508.75 KRW | 20.42% |
| 2018 Q3 | 381.42 KRW | -30.17% |
| 2018 Q4 | 322.51 KRW | -15.44% |
| 2018 FY | - KRW | -33.33% |
| 2018 Q1 | 551.41 KRW | -28.75% |
| 2018 Q2 | 546.24 KRW | -0.94% |
| 2017 Q2 | 775.79 KRW | 68.88% |
| 2017 FY | - KRW | 131.04% |
| 2017 Q4 | 773.92 KRW | 10.62% |
| 2017 Q3 | 699.65 KRW | -9.81% |
| 2017 Q1 | 459.38 KRW | 25.77% |
| 2016 Q4 | 365.25 KRW | -4.77% |
| 2016 Q3 | 383.53 KRW | -2.06% |
| 2016 Q1 | 72.52 KRW | -80.03% |
| 2016 FY | - KRW | 5.49% |
| 2016 Q2 | 391.58 KRW | 439.96% |
| 2015 Q1 | -103.26 KRW | -213.39% |
| 2015 Q3 | 428.68 KRW | 6.41% |
| 2015 Q4 | 363.07 KRW | -15.31% |
| 2015 Q2 | 402.86 KRW | 490.14% |
| 2015 FY | - KRW | 26.46% |
| 2014 Q2 | 503.63 KRW | 412.13% |
| 2014 FY | - KRW | 9.99% |
| 2014 Q4 | 91.07 KRW | -14.52% |
| 2014 Q3 | 106.54 KRW | -78.85% |
| 2014 Q1 | 98.34 KRW | 454.76% |
| 2013 Q3 | 261.84 KRW | 2.55% |
| 2013 FY | - KRW | -70.4% |
| 2013 Q4 | -27.72 KRW | -110.59% |
| 2013 Q1 | 236.52 KRW | -66.65% |
| 2013 Q2 | 255.33 KRW | 7.95% |
| 2012 FY | - KRW | 109.6% |
| 2012 Q1 | 301.90 KRW | -24.24% |
| 2012 Q3 | 478.01 KRW | -3.31% |
| 2012 Q4 | 709.16 KRW | 48.36% |
| 2012 Q2 | 494.37 KRW | 63.75% |
| 2011 Q3 | 302.74 KRW | 1.12% |
| 2011 Q2 | 299.39 KRW | 3.48% |
| 2011 Q1 | 289.32 KRW | 23.7% |
| 2011 FY | - KRW | 47.7% |
| 2011 Q4 | 398.49 KRW | 31.63% |
| 2010 Q2 | 223.91 KRW | 49.16% |
| 2010 Q1 | 150.11 KRW | -3.57% |
| 2010 Q3 | 223.07 KRW | -0.38% |
| 2010 Q4 | 233.89 KRW | 4.85% |
| 2010 FY | - KRW | 70.86% |
| 2009 Q4 | 155.66 KRW | 52.15% |
| 2009 FY | - KRW | 287.15% |
| 2009 Q3 | 102.31 KRW | -24.69% |
| 2009 Q2 | 135.86 KRW | 40.88% |
| 2009 Q1 | 96.44 KRW | 6939.42% |
| 2008 Q1 | 26.00 KRW | -66.09% |
| 2008 Q3 | 108.18 KRW | 151.19% |
| 2008 Q4 | 1.37 KRW | -98.73% |
| 2008 FY | - KRW | -62.05% |
| 2008 Q2 | -211.33 KRW | -912.81% |
| 2007 Q4 | 76.68 KRW | -28.61% |
| 2007 Q2 | 63.74 KRW | -29.25% |
| 2007 Q1 | 90.09 KRW | 0.0% |
| 2007 FY | - KRW | 0.0% |
| 2007 Q3 | 107.41 KRW | 68.51% |
| Name | Eps | Eps Difference |
|---|---|---|
| ORIENT BIO Inc. | 108.55 KRW | -3362.92% |
| Green Cross Holdings Corporation | -1210.00 KRW | 410.661% |
| Green Cross Holdings Corporation | -2333.42 KRW | 261.094% |
| Pharmicell Co., Ltd. | 60.00 KRW | -6165.0% |
| Green Cross Corporation | -2333.42 KRW | 261.094% |
| GeneOne Life Science, Inc. | -1000.23 KRW | 475.814% |
| Samsung Biologics Co.,Ltd. | 12.05 Thousand KRW | 68.805% |
| SK bioscience Co.,Ltd. | 291.00 KRW | -1191.753% |
| SK Biopharmaceuticals Co., Ltd. | -419.89 KRW | 995.234% |
| Prestige BioPharma Limited | -547.81 KRW | 786.187% |